260 related articles for article (PubMed ID: 19025119)
1. Complement factor H: using atomic resolution structure to illuminate disease mechanisms.
Barlow PN; Hageman GS; Lea SM
Adv Exp Med Biol; 2008; 632():117-42. PubMed ID: 19025119
[TBL] [Abstract][Full Text] [Related]
2. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
de Córdoba SR; de Jorge EG
Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
[TBL] [Abstract][Full Text] [Related]
3. Factor H family proteins and human diseases.
Józsi M; Zipfel PF
Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
[TBL] [Abstract][Full Text] [Related]
4. Disease-associated sequence variations in factor H: a structural biology approach.
Herbert AP; Soares DC; Pangburn MK; Barlow PN
Adv Exp Med Biol; 2006; 586():313-27. PubMed ID: 16893081
[No Abstract] [Full Text] [Related]
5. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
6. [The role of complement in physiology and pathology].
Klaska I; Nowak JZ
Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
[TBL] [Abstract][Full Text] [Related]
7. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.
Pickering MC; Cook HT
Clin Exp Immunol; 2008 Feb; 151(2):210-30. PubMed ID: 18190458
[TBL] [Abstract][Full Text] [Related]
8. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.
Morgan HP; Jiang J; Herbert AP; Kavanagh D; Uhrin D; Barlow PN; Hannan JP
Acta Crystallogr D Biol Crystallogr; 2011 Jul; 67(Pt 7):593-600. PubMed ID: 21697597
[TBL] [Abstract][Full Text] [Related]
10. The role of complement in AMD.
Zipfel PF; Lauer N; Skerka C
Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
[TBL] [Abstract][Full Text] [Related]
11. Complement factor H and the hemolytic uremic syndrome.
Atkinson JP; Goodship TH
J Exp Med; 2007 Jun; 204(6):1245-8. PubMed ID: 17548524
[TBL] [Abstract][Full Text] [Related]
12. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
13. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
[TBL] [Abstract][Full Text] [Related]
14. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Noris M; Remuzzi G
Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
[TBL] [Abstract][Full Text] [Related]
15. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
Aslam M; Perkins SJ
J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for engagement by complement factor H of C3b on a self surface.
Morgan HP; Schmidt CQ; Guariento M; Blaum BS; Gillespie D; Herbert AP; Kavanagh D; Mertens HD; Svergun DI; Johansson CM; Uhrín D; Barlow PN; Hannan JP
Nat Struct Mol Biol; 2011 Apr; 18(4):463-70. PubMed ID: 21317894
[TBL] [Abstract][Full Text] [Related]
17. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties.
Okemefuna AI; Gilbert HE; Griggs KM; Ormsby RJ; Gordon DL; Perkins SJ
J Mol Biol; 2008 Jan; 375(1):80-101. PubMed ID: 18005991
[TBL] [Abstract][Full Text] [Related]
18. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.
Nan R; Gor J; Perkins SJ
J Mol Biol; 2008 Jan; 375(4):891-900. PubMed ID: 18054958
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H and haemolytic uraemic syndrome.
Mathieson P
Lancet; 2002 Mar; 359(9308):801-2. PubMed ID: 11888630
[No Abstract] [Full Text] [Related]
20. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.
Jokiranta TS; Solomon A; Pangburn MK; Zipfel PF; Meri S
J Immunol; 1999 Oct; 163(8):4590-6. PubMed ID: 10510403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]